Outset Medical, Inc.

Equities

OM

US6901451079

Advanced Medical Equipment & Technology

Delayed Nasdaq Other stock markets 20:57:39 23/05/2024 BST			5-day change	1st Jan Change
3.98 ^USD	+1.92%		+13.07%	-26.43%

05-14	Transcript : Outset Medical, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 11:20 AM
05-13	Morgan Stanley Lowers Price Target on Outset Medical to $4.50 From $5.50, Keeps Equalweight Rating	MT

Outset Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024

May 08, 2024 at 09:02 pm

Outset Medical, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported revenue was USD 28.17 million compared to USD 33.47 million a year ago. Net loss was USD 39.94 million compared to USD 43.97 million a year ago.

Basic loss per share from continuing operations was USD 0.78 compared to USD 0.9 a year ago. Diluted loss per share from continuing operations was USD 0.78 compared to USD 0.9 a year ago.

Latest news about Outset Medical, Inc.

Transcript : Outset Medical, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 11:20 AM	05-14
Morgan Stanley Lowers Price Target on Outset Medical to $4.50 From $5.50, Keeps Equalweight Rating	05-13	MT
Transcript : Outset Medical, Inc., Q1 2024 Earnings Call, May 08, 2024	05-08
Earnings Flash (OM) OUTSET MEDICAL Reports Q1 Revenue $28.2M, vs. Street Est of $30.3M	05-08	MT
Outset Medical, Inc. Reaffirms Earnings Guidance for the Year 2024	05-08	CI
Outset Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-08	CI
Sector Update: Health Care Stocks Advance in Monday Afternoon Trading	05-06	MT
Outset Medical Shares Rise on US FDA 510(k) Clearance for TabloCart With Prefiltration	05-06	MT
Outset Medical Shares Rise 56% After FDA Grants Clearance for TabloCart	05-06	DJ
Outset Medical Receives US FDA 510(k) Clearance for TabloCart With Prefiltration -- Shares Surge 13% Pre-Bell	05-06	MT
Outset Medical, Inc. Receives FDA 510(K) Clearance for Tablocart with Prefiltration	05-06	CI
Outset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S	04-17	CI
BTIG Initiates Outset Medical at Buy Rating With $6 Price Target	04-08	MT
Outset Medical, Inc. Announces Board Changes	03-13	CI
RBC Reduces Price Target on Outset Medical to $5 From $6, Keeps Sector Perform Rating	02-22	MT
Transcript : Outset Medical, Inc., Q4 2023 Earnings Call, Feb 21, 2024	02-21
Earnings Flash (OM) OUTSET MEDICAL Reports Q4 Revenue $30.5M, vs. Street Est of $30.1M	02-21	MT
Outset Medical, Inc. Announces Departure of Steve Williamson as Chief Commercial Officer, Effective March 1, 2024	02-21	CI
Outset Medical, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	02-21	CI
Outset Medical, Inc. Reaffirms Earnings Guidance for 2024	02-21	CI
North American Morning Briefing : Stock Futures -2-	01-16	DJ
Outset Medical Shares Drop After RBC Downgrade	01-12	MT
RBC Downgrades Outset Medical to Sector Perform From Outperform, Slashes Price Target to $6 From $14	01-12	MT
Transcript : Outset Medical, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 05:15 PM	01-09
Outset Medical, Inc. Provides Revenue Guidance for the Year 2024	01-08	CI

Chart Outset Medical, Inc.

Duration

Period

More charts

Company Profile

Outset Medical, Inc. is a medical technology company. The Company offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. The Company designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by virtually anyone. The Tablo system comprises components, which include Tablo Console, Tablo Cartridge and Tablo Data Ecosystem. Tablo Console is a compact, mobile and versatile machine consisting of an integrated water purification, on-demand dialysate production system and touchscreen interface with 3D animations. It also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.

Sector

Advanced Medical Equipment & Technology

Calendar

29/05/2024 - Annual General Meeting

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Outset Medical, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

3.905 USD

Average target price

5.643 USD

Spread / Average Target

+44.50%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
OUTSET MEDICAL, INC.	-26.43%	202M
THERMO FISHER SCIENTIFIC	+10.09%	226B
DANAHER CORPORATION	+12.98%	198B
INTUITIVE SURGICAL, INC.	+18.01%	142B
BOSTON SCIENTIFIC CORPORATION	+28.65%	111B
SIEMENS HEALTHINEERS AG	+2.09%	65.26B
EDWARDS LIFESCIENCES CORPORATION	+14.63%	54.36B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+6.68%	50.94B
AGILENT TECHNOLOGIES, INC.	+8.11%	44.8B
GE HEALTHCARE TECHNOLOGIES INC.	+2.72%	36.8B

Other Advanced Medical Equipment & Technology